Lv2
130 积分 2025-01-05 加入
Abstract P4-08-09: Phase 3, Randomized, Open-label TroFuse-010 Study of Sacituzumab Tirumotecan (sac-TMT) Alone & W/ Pembrolizumab vs. Treatment of Physician’s Choice Chemotherapy in Patients With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer
1天前
求助中
MO27-5 TroFuse-008: phase 1 study of TROP2-targeted ADC sacituzumab tirumotecan (Sac-TMT) in advanced solid tumors
1天前
求助中
TROFUSE-020/GOG-3101/ENGOT-CX20: A PHASE 3, RANDOMIZED, ACTIVE-CONTROLLED, OPEN-LABEL, MULTICENTER STUDY COMPARING SACITUZUMAB TIRUMOTECAN MONOTHERAPY VS TREATMENT OF PHYSICIAN’S CHOICE AS SECOND-LINE TREATMENT FOR RECURRENT/METASTATIC CERVICAL CANCER
1天前
求助中
Sacituzumab tirumotecan improves OS in EGFR TKI-resistant NSCLC
2天前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
2天前
已完结
Nanosized FeS/ZnS heterojunctions derived using zeolitic imidazolate Framework-8 (ZIF-8) for pH-universal oxygen reduction and High-efficiency Zn–air battery
1个月前
已完结
皖公网安备34019202002308
